These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 971444)

  • 21. Inhibition of 5-hydroxyindoleacetic acid transport from the spinal fluid by probenecid.
    Zivković B; Bulat M
    J Pharm Pharmacol; 1971 Jul; 23(7):539-40. PubMed ID: 4397456
    [No Abstract]   [Full Text] [Related]  

  • 22. Brain extracellular space in developing normal and hydrocephalic kittens using ventriculocisternal perfusion.
    Shaywitz BA; Escriva A
    Neurology; 1970 Apr; 20(4):394-5. PubMed ID: 5535028
    [No Abstract]   [Full Text] [Related]  

  • 23. Failure of buffered 5-hydroxytryptamine to increase brain capillary permeability to albumin in monkeys.
    Solomon LS
    J Neurosurg; 1974 Jun; 40(6):717-25. PubMed ID: 4207875
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of probenecid on cerebral and cisternal cerebrospinal fluid lactate content.
    MacMillan V
    J Cereb Blood Flow Metab; 1987 Feb; 7(1):118-23. PubMed ID: 2433297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cation exchange in blood, brain and CSF.
    Katzman R; Graziani L; Ginsburg S
    Prog Brain Res; 1968; 29():283-96. PubMed ID: 5735114
    [No Abstract]   [Full Text] [Related]  

  • 26. Mechanisms for the elimination of 5-hydroxyindoleacetic acid from brain and cerebrospinal fluid of the rat during postnatal development.
    Atack C; Bass NH; Lundborg P
    Brain Res; 1974 Aug; 77(1):111-20. PubMed ID: 4853133
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of probenecid on the elimination from CSF of intraventricularly injected 5-hydroxyindolecetic acid in normal and hydrocephalic dogs.
    Anderson H; Roos BE
    J Pharm Pharmacol; 1968 Nov; 20(11):879-81. PubMed ID: 4387498
    [No Abstract]   [Full Text] [Related]  

  • 28. [Role of active transport of 5-hydroxyindoleacetic acid in serotonin metabolism in the brain].
    Molodtsova GF
    Ross Fiziol Zh Im I M Sechenova; 2004 Apr; 90(4):490-4. PubMed ID: 15296070
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of probenecid and its congeners on brain organic acid transport in rats.
    Altagracia M; Rios C; Kravzov J; López-Naranjo F
    Proc West Pharmacol Soc; 1993; 36():215-7. PubMed ID: 7690972
    [No Abstract]   [Full Text] [Related]  

  • 30. A pilot study of some kinetic aspects of the metabolism of 5-hydroxytryptamine in depressive patients.
    van Praag HM; Korf J
    Biol Psychiatry; 1971; 3(2):105-12. PubMed ID: 5089909
    [No Abstract]   [Full Text] [Related]  

  • 31. Active transport of methotrexate from cerebrospinal fluid in humans.
    Bode U; Magrath IT; Bleyer WA; Poplack DG; Glaubiger DL
    Cancer Res; 1980 Jul; 40(7):2184-7. PubMed ID: 7388786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain.
    Moir AT; Ashcroft GW; Crawford TB; Eccleston D; Guldberg HC
    Brain; 1970; 93(2):357-68. PubMed ID: 4912291
    [No Abstract]   [Full Text] [Related]  

  • 33. 5-Hydroxytrytophan as an antidepressant. The predictive value of the probenecid test.
    van Praag HM; Korf J
    J Nerv Ment Dis; 1974 May; 158(5):331-7. PubMed ID: 4596091
    [No Abstract]   [Full Text] [Related]  

  • 34. Acidic and neutral metabolites of norepinephrine: their metabolism and transport from brain.
    Meek JL; Neff NH
    J Pharmacol Exp Ther; 1972 Jun; 181(3):457-62. PubMed ID: 5033012
    [No Abstract]   [Full Text] [Related]  

  • 35. Perfusion of the subarachnoid space from above the corpus callosum to the cisterna magna--transport of potassium at the blood-brain barrier.
    Bradbury MW; Wilson J
    J Physiol; 1971 Oct; 218 Suppl():8P-9P. PubMed ID: 5130657
    [No Abstract]   [Full Text] [Related]  

  • 36. Penetration into and elimination from the cerebrospinal fluid of diltiazem, a calcium antagonist, in anesthetized rabbits.
    Naito K; Nagao T; Otsuka M; Harigaya S; Nakajima H
    Arzneimittelforschung; 1986; 36(1):25-8. PubMed ID: 3954820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Penetration of 5-hydroxyindoleacetic acid across the blood-cerebrospinal fluid barrier.
    Bulat M; Zivković B
    J Pharm Pharmacol; 1973 Feb; 25(2):178-9. PubMed ID: 4146555
    [No Abstract]   [Full Text] [Related]  

  • 38. Exchange of 5-hydroxyindoleacetic acid between the spinal cord and lumbar cerebrospinal fluid.
    Bulat M; Zivković B
    J Physiol; 1978 Feb; 275():191-7. PubMed ID: 633105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo measurements by differential pulse voltammetry of extra-cellular 5-hydroxyindoleacetic acid in the rat brain.
    Cespuglio R; Faradji H; Ponchon JL; Riou F; Buda M; Gonon F; Pujol JF; Jouvet M
    J Physiol (Paris); 1981; 77(2-3):327-32. PubMed ID: 6169830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain inulin space in developing kittens using ventriculocisternal perfusion.
    Shaywitz BA
    Neurology; 1972 Mar; 22(3):238-45. PubMed ID: 5066920
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.